Aktywa Zmiana Data
AbbVie USD 147.68B 12.57B 2026-09
Alcon AG USD 31.37B 270M 2026-09
Almirall EUR 2.37B 29.97M 2026-06
Amgen USD 96.05B 409M 2026-09
argenx SE USD 10.03B 1.35B 2026-06
AstraZeneca USD 119.92B 4.09B 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Biogen USD 32.05B 32.5M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Fresenius EUR 42.24B 401M 2026-09
Fresenius Medical Care EUR 31.45B 155.97M 2026-09
Genmab DKK 12.52B 139M 2026-06
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Glaxosmithkline GBP 71.7B 8.83B 2026-09
GRIFOLS EUR 20.28B 191M 2026-09
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lakefront Biotherapeutics EUR 3.29B 56.62M 2026-09
Lonza CHF 18.97B 164M 2025-12
Merck EUR 53.66B 975M 2026-09
Merck USD 132.77B 2.97B 2026-09
Novartis USD 117.15B 4.88B 2026-09
Novo Nordisk DKK 594.94B 35.72B 2026-06
Orion EUR 2.03B 160.3M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Philips EUR 28.03B 1.33B 2026-09
Recordati EUR 5.46B 89.21M 2026-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
Smith & Nephew USD 11.01B 321M 2026-06
UCB EUR 18.16B 971M 2025-12